EMAS and IGCS Position statement on managing the menopause after gynecological cancer

European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position statement on managing the menopause after gynecological cancer Worldwide, 1.3 million new gynecological cancer cases are diagnosed each year. Treatment can result in loss of ovarian function and, in women under the age of 45, early menopause.  This position statement provides an…

Maturitas Paper of the Year

Risk of asthma onset after natural and surgical menopause: Results from the French E3N cohort Bobette Matulonga-Diakiese, Dominique Courbon, Agnès Fournier, Margaux Sanchez, Annabelle Bédard, Sylvie Mesrine, Camille Taillé, Gianluca Severi, Gabriel Thabut, Raphaëlle Varraso, Bénédicte Leynaert Maturitas, Vol. 118, p44–50. https://www.maturitas.org/article/S0378-5122(18)30325-6/abstract

EMAS travel award

EMAS travel award EMAS will support the travel costs for junior members who wish to attend international meetings and congresses; or, for example, those who wish to visit laboratories for specific short-term activities, such as collaborative research, or in order to learn new techniques. This is subject to them meeting the assessment criteria for these…

#EMAS2019 in the news

#EMAS2019 in the news Integrating novel scientific insights into clinical application the multidisciplinary international congress was extremely successful and enjoyed by all participants. As part of its menopause week, the BBC filmed speakers on both women’s and men’s health. The clips are below. We look forward to May 2021 when the next congress will be in…


Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond publishing original research, reviews, consensus statements and guidelines. Published by Elsevier Science. Impact Factor 2018 3.654